YPrime's enhanced eCOA localization capabilities address this need by providing a seamless, efficient process for implementing multilingual deployments. The company's innovative new approach empowers ...
Clinical ink, a global life science technology company, is expanding its patient engagement solutions with the inclusion into its 21 CFR Part 11 platform of the SPURtm behavioral assessment tool and ...
“The major functionality upgrades in the development plan for 2023 include eConsent, aimed at making it more straightforward for patients to consent as part of the clinical trial ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
USAID's stop-work order threatens to undo decades of progress in medical research ethics and cause harm to clinical trial ...
Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss potential strategies that teams can implement to ensure ...
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical research across the U.S.
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results